SeerPharma is a strategic partner with market-leading software solution provider – MasterControl. Our partnership, over the last 7 years, has seen us deploy this solution to digitise Quality and Manufacturing workflows to over 85 companies across the APAC region. In that time, we have seen our clients utilise MasterControl to break down silos and...
Students enrolled in our Postgraduate Good Manufacturing Practice (GMP) Program at UTS engage in a range of subjects, each spanning 10 weeks and guided by our Consulting team. Throughout their studies, they delve into various topics, such as International GMPs and QA, Validation Principles, GxP, Quality Auditing, and Computer Systems Validation.
I began university studying Medical Science and Law in 2016, before deciding to continue with just Medical Science after two years - this turned out to be a good decision, as I was then able to graduate just before COVID hit. During the pandemic, I was fortunate enough to find a job within my field, working for veterinary pharmaceutical company...
For over eight years, SeerPharma has partnered with the University of Technology Sydney (UTS), offering cutting-edge, university-accredited graduate programs on Good Manufacturing Practice (GMP). As the only course of its kind in the Asia-Pacific region, this collaboration underscores a commitment to advancing expertise in Quality/GMP within the...
This article was originally published by SeerPharma's business partner University of Technology Sydney (UTS) and is republished in-part here with their permission.
The pharmaceutical and medical device industry is currently experiencing unprecedented growth, with projections indicating a staggering $1.7 trillion valuation by 2030. Yet, amidst this dynamic expansion, manufacturers grapple with intense competition, tightening regulations and an unrelenting demand for innovation in bringing new therapies and/or...
$50,000 matched funding is now available through the MedTech Market Growth Program, a collaboration between the Australian Medtech Manufacturing Centre and LaunchVic, Victoria’s startup agency.
The inclusion of medical devices onto the Therapeutic Goods Administration's (TGA’s) Australian Register of Therapeutic Goods (ARTG) requires manufacturers to demonstrate that their device meets specific safety and performance characteristics and has been designed and manufactured in accordance with the Essential Principles.
For most medical device manufacturers, the roadmap to market will start with ISO 13485:2016 certification. Obtaining an ISO 13485:2016 certificate is evidence that the Quality Management System in place is compliant with international standards and is a key component of a registration package with the regulators.
SeerPharma welcomes the 2024 Autumn cohort of students studying Good Manufacturing Practice (GMP) at the University of Technology Sydney (UTS). The program continues to grow from strength to strength, and we’re thrilled to see a record number of enrolments, with over 95 new students joining us this year. The course continues to attract and engage...
Copyright © SeerPharma
